Araris Biotech Company
Araris Biotech is a biotechnology company that develops antibody-drug conjugates using a proprietary linker technology designed for efficient payload attachment without antibody engineering. The company's platform enables the creation of stable, homogenous ADCs with improved therapeutic efficacy and reduced side effects. The company focuses on advancing targeted cancer treatments by streamlining the ADC development process.
Investors
Connections
Employee Number:
11-50
Headquarters:
Zürich, Zurich, Switzerland, Europe
Founded Date:
2019-01-01
Industry:
Drug Discovery & Development
Super Industry:
Biopharma & Life Science Tools
Phone Number:
+41 56 310 45 98
Investors:
4BIO Capital, Schroders Capital, VI Partners, b2venture, redalpine
Ipo Status:
private
City:
Zürich
Region:
Zurich
Country:
Switzerland
Founders:
Dragan Grabulovski, Isabella Attinger-Toller, Philipp Spycher